SK bioscience

본문바로가기

KOR ENG

sitemap

PR

SK bioscience company news updates

Press releases

SK bioscience-Novavax Extend Collaboration and Contract Manufacturing Agreements of COVID-19 Vaccine

2021. 12. 24
SK bioscience and CEPI Expand Partnership to Develop A New Universal Vaccine against variants of SARS-CoV and SARS-CoV-2

2021. 12. 21
SK bioscience Announces New Executive Promotions for 2022

2021. 12. 2
SK bioscience and Korea University Medicine Center Establish Partnership to Respond to Infectious Diseases

2021. 12. 2
SK bioscience Partners with IVI to Launch New Prestigious Award for Vaccine Industry

2021. 11. 30
SK bioscience Submits Biologics License Application to the KMFDS for Novavax Covid-19 Vaccine Candidate

2021. 11. 15
SK bioscience Announces Positive Data from Phase I/II Clinical Trial of COVID-19 Vaccine Candidate

2021. 11. 05
SK bioscience and CEPI Extend Agreement Contract Production of COVID-19 Vaccines by the End of 2022

2021. 10. 06
SK bioscience Enters the Third Phase of Clinical Trial of COVID-19 Vaccine Candidate

2021. 08. 30
SK bioscience Initiates Phase III Clinical Trial of COVID-19 Vaccine Candidate with Promising Interim Data

2021. 08. 10